HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mikael Peräkylä Selected Research

Ligands

7/2012Design, synthesis, and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mikael Peräkylä Research Topics

Disease

4Prostatic Neoplasms (Prostate Cancer)
04/2014 - 07/2004
2Breast Neoplasms (Breast Cancer)
05/2010 - 02/2010
2Neoplasms (Cancer)
02/2010 - 08/2005
1HIV Infections (HIV Infection)
06/2014
1Neoplasm Metastasis (Metastasis)
02/2010
1Osteoporosis
08/2005
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2005

Drug/Important Bio-Agent (IBA)

2azasteneIBA
04/2014 - 07/2012
2benzonitrileIBA
04/2014 - 07/2012
2bicalutamide (Casodex)FDA LinkGeneric
04/2014 - 07/2012
2TrypsinIBA
02/2010 - 07/2004
1Proteins (Proteins, Gene)FDA Link
06/2014
1Antiviral Agents (Antivirals)IBA
06/2014
1ThiazinesIBA
06/2014
1Androgen Antagonists (Antiandrogens)IBA
04/2014
1enzalutamideIBA
04/2014
1Hormones (Hormone)IBA
04/2014
1IsoxazolesIBA
04/2014
1SteroidsIBA
04/2014
1Androgen Receptors (Androgen Receptor)IBA
04/2014
1AndrogensIBA
04/2014
1hydroxyflutamideIBA
07/2012
1LigandsIBA
07/2012
1Estradiol (Delestrogen)FDA LinkGeneric
05/2010
125-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
02/2010
1Calcifediol (Calcidiol)FDA Link
02/2010
1EnzymesIBA
02/2010
1Peptides (Polypeptides)IBA
02/2010
1Proteinase-Activated ReceptorsIBA
02/2010
1CD4528IBA
08/2005
1Prostate-Specific Antigen (Semenogelase)IBA
07/2004
1Kallikreins (Kallikrein)IBA
07/2004
1Serine Proteases (Serine Protease)IBA
07/2004

Therapy/Procedure

1Therapeutics
08/2005